MERCK & CO., INC. (MRK)
Clinical trial NCT04305054 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-20 → 2026-05-18 3. primary completion date: 2026-05-20 → 2026-05-18 4. enrollment: not set → 335 participants
Clinical trial NCT04305054 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-20 → 2026-05-18 3. primary completion date: 2026-05-20 → 2026-05-18 4. enrollment: not set → 335 participants
📉 **NEGATIVE** • Medium confidence analysis (72%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (18%) **Content type:** Clinical